» Articles » PMID: 2981319

Evidence Suggesting an Ra-type Adenosine Receptor in Bovine Coronary Arteries

Overview
Specialty Pharmacology
Date 1985 Jan 1
PMID 2981319
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

It has been reported that adenosine has two extracellular membrane receptors depending upon the activation (Ra) or inhibition (Ri) of the adenylate cyclase system. At the Ra site, 5'-N-ethylcarboxamideadenosine is more potent than N6-L-phenylisopropyladenosine (L-PIA) and the reverse is true for the Ri site. Therefore, the aim of this investigation was to characterize the subtype of adenosine receptor in bovine coronary arteries with the use of several adenosine analogs. The order of potency for several of these analogs was found to be: 5'-N-ethylcarboxamideadenosine greater than 5'-N-cyclopropylcarboxamideadenosine greater than L-PIA greater than N6-cyclohexyladenosine greater than 2-Cl-adenosine greater than adenosine greater than D-PIA. The concentration-response curves were parallel to each other, which suggests the same receptor site. L-Adenosine, L-5'-N-ethylcarboxamideadenosine, and methyl-N6-cyclohexyladenosine and 2'-5'-dideoxyadenosine (P site analog) were found to be ineffective in relaxing the bovine coronary arteries. The difference between L- and D-PIA was less than 100-fold. This hierarchy suggested the existence of Ra subtype adenosine receptor in bovine coronary arteries. Both theophylline and 8-phenyltheophylline antagonized the relaxing effect of various analogs and shifted the concentration-response curve to the right in parallel. 8-Phenyltheophylline was severalfold more potent in its antagonistic effect than theophylline. In addition, inosine caused the dilation of both large and small coronary arteries at 1 X 10(-4)M and 1 X 10(-3)M concentrations (adenosine would cause a similar relaxation at 500-fold less concentration).(ABSTRACT TRUNCATED AT 250 WORDS)

Citing Articles

The Role of Adenosine A Receptor, CYP450s, and PPARs in the Regulation of Vascular Tone.

Khayat M, Nayeem M Biomed Res Int. 2017; 2017:1720920.

PMID: 28884118 PMC: 5572598. DOI: 10.1155/2017/1720920.


Drug Delivery and Nanoformulations for the Cardiovascular System.

Geldenhuys W, Khayat M, Yun J, Nayeem M Res Rev Drug Deliv. 2017; 1(1):32-40.

PMID: 28713881 PMC: 5507069.


CYP-epoxygenases contribute to A2A receptor-mediated aortic relaxation via sarcolemmal KATP channels.

Ponnoth D, Nayeem M, Tilley S, Ledent C, Mustafa S Am J Physiol Regul Integr Comp Physiol. 2012; 303(10):R1003-10.

PMID: 23019210 PMC: 3774479. DOI: 10.1152/ajpregu.00335.2012.


Role of ω-hydroxylase in adenosine-mediated aortic response through MAP kinase using A2A-receptor knockout mice.

Ponnoth D, Nayeem M, Kunduri S, Tilley S, Zeldin D, Ledent C Am J Physiol Regul Integr Comp Physiol. 2011; 302(4):R400-8.

PMID: 22160543 PMC: 3293507. DOI: 10.1152/ajpregu.00481.2011.


Absence of adenosine-mediated aortic relaxation in A(2A) adenosine receptor knockout mice.

Ponnoth D, Sanjani M, Ledent C, Roush K, Krahn T, Mustafa S Am J Physiol Heart Circ Physiol. 2009; 297(5):H1655-60.

PMID: 19749167 PMC: 2781374. DOI: 10.1152/ajpheart.00192.2009.